Ceftazidime–avibactam for carbapenem-resistant Klebsiella pneumoniae infections: determining mortality predictors in the intensive care unit
Carbapenem-resistant Klebsiella pneumoniae (CRKP) represent a significant global threat. The objective of this study is to provide a comprehensive description of the clinical course and outcomes of patients with CRKP infections treated with ceftazidime avibactam (CAZ-AVI) in comparison to patients treated wit...